Procter & Gamble Health Ltd banner

Procter & Gamble Health Ltd
NSE:PGHL

Watchlist Manager
Procter & Gamble Health Ltd Logo
Procter & Gamble Health Ltd
NSE:PGHL
Watchlist
Price: 5 216.9 INR 1.59% Market Closed
Market Cap: ₹86.6B

P/E

29.5
Current
19%
Cheaper
vs 3-y average of 36.5

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
29.5
=
Market Cap
₹85.1B
/
Net Income
₹2.9B

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
29.5
=
Market Cap
₹85.1B
/
Net Income
₹2.9B

Valuation Scenarios

Procter & Gamble Health Ltd is trading below its 3-year average

If P/E returns to its 3-Year Average (36.5), the stock would be worth ₹6 446.44 (24% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-3%
Maximum Upside
+27%
Average Upside
13%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 29.5 ₹5 216.9
0%
3-Year Average 36.5 ₹6 446.44
+24%
5-Year Average 37.4 ₹6 613.59
+27%
Industry Average 30.4 ₹5 367.24
+3%
Country Average 28.7 ₹5 075.22
-3%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
₹85.1B
/
Jan 2026
₹2.9B
=
29.5
Current
₹85.1B
/
Mar 2026
₹3.2B
=
26.5
Forward
₹85.1B
/
Mar 2027
₹3.7B
=
23.3
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Peer Comparison

All Countries
Close

Market Distribution

In line with most companies in India
Percentile
51st
Based on 3 123 companies
51st percentile
29.5
Low
0 — 18.9
Typical Range
18.9 — 44.4
High
44.4 —
Distribution Statistics
India
Min 0
30th Percentile 18.9
Median 28.7
70th Percentile 44.4
Max 877 228.1

Procter & Gamble Health Ltd
Glance View

Market Cap
86.6B INR
Industry
Pharmaceuticals

In the vast landscape of healthcare, Procter & Gamble Health Ltd. carves its niche by blending science with daily life, transforming mundane routines into healthier lifestyles. Originally known for its parent company’s deep roots in consumer goods, P&G Health Ltd. has transitioned seamlessly into the pharmaceutical domain, focusing on over-the-counter (OTC) health products and supplements. Its journey is one of leveraging brand trust and an extensive distribution network to ensure that essential health solutions are accessible to consumers around the globe. P&G Health's emphasis on consumer awareness and education propels its growth, as it capitalizes on the modern consumer’s desire for self-care and proactive health management. At the heart of its business model lies a portfolio of products that spans various health categories, encapsulating vitamins, minerals, and supplements that address widespread health needs such as digestive wellness and immunity. The company thrives on innovation and strategic collaboration, utilizing a mix of in-house research alongside partnerships to remain at the forefront of consumer health trends. Revenue streams are buoyed by the strength of its established global market presence and regional expertise, ensuring adaptability across diverse economic landscapes. By catering to both established and emerging markets, Procter & Gamble Health Ltd. sustains its growth momentum, continuously refining its product offerings to meet the dynamic demands of health-conscious consumers.

PGHL Intrinsic Value
4 046.26 INR
Overvaluation 22%
Intrinsic Value
Price ₹5 216.9
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett